Flu vaccine development4th May 2006
The U.S. Health and Human Services Department have awarded five companies, including GlaxoSmithKline, more than $1 billion (540 million pounds) in contracts to develop new and better influenza vaccines.
The companies will all work to develop cell based-vaccines to fight influenza; GlaxoSmithKline was awarded $274.75 million (148.60 million pounds), MedImmune was awarded $169.46 million, Novartis AG won $220.51 million, DynPort vaccine, working with Baxter International Inc. , won $40.97 million and Solvay won $298.59 million.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Flu vaccine development
Author: Sue Knights
Article Id: 273
Date Added: 4th May 2006